Bed Nucleus Of The Stria Terminalis Pituitary Adenylate Cyclase Activating Peptide Projections To The Central Nervous System Regions
2020
- 123Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage123
- Abstract Views82
- Downloads41
Thesis / Dissertation Description
Pituitary adenylate cyclase activating peptide (PACAP) is a pleiotropic neuropeptide that has vast functions, ranging from behavioral, to endocrine, cardiovascular, and cellular, in which often these effects are biphasic. This paper will focus on the effects of PACAP within the central nervous system (CNS), specifically in response to stress and anxiety. PACAP has been extensively researched in terms of its effect on the stress response and is well-known for its effects in inducing anxiety-like behaviors. PACAP induces such effects through working in regions of the CNS such as the amygdala, hypothalamus, and bed nucleus of the stria terminalis (BNST). Research has shown that injecting PACAP into the BNST produces anxiogenic effects; this is backed up by in situ hybridization and mRNA studies. While it is known that BNST-PACAP signaling produces such behavior, it is not fully clear how these processes are connected to other CNS regions that are implicated in the stress-response or have been shown to hold PACAP neurons.Using Cre-recombinase technology, this study mapped BNST-PACAP projections to various CNS nuclei, specifically anterior projections to the nucleus accumbens, intrinsic BNST signaling, and posterior projections to the medial habenular nucleus (MHb), amygdala and hypothalamic regions. These projections occurred via three fiber pathways: stria terminalis, stria medullaris, and forebrain projections. The novel finding was of BNST-PACAP projections within the MHb via stria medullaris, as well as the conformation of one-directional BNST-PACAP projections to the amygdala via the stria terminalis and anterior projections to the nucleus accumbens.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know